Pieris Pharmaceuticals In... (PIRS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

13.26

0.00%

After-hours Dec 13, 2024, 04:03 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	42.81M	25.90M	31.42M	29.32M	46.28M	29.10M	25.27M	5.83M	2.93M	5.37M	9.88M	11.38M
Cost of Revenue	41.80M	2.78M	2.37M	46.53M	55.00M	-	-	-	-	-	-2.55M	-
Gross Profit	1.01M	23.12M	29.05M	-17.21M	-8.72M	29.10M	25.27M	5.83M	2.93M	5.37M	12.43M	11.38M
Operating Income	-29.76M	-43.47M	-51.83M	-33.92M	-27.16M	-30.83M	-14.59M	-22.76M	-13.68M	-7.20M	553.83K	-2.18M
Interest Income	1.85M	721.00K	4.00K	511.00K	1.71M	1.96M	152.00K	2.32K	-	-	-	177.13K
Pretax Income	-24.54M	-33.28M	-45.74M	-37.07M	-25.47M	-27.07M	-16.54M	-22.64M	-13.85M	-9.85M	66.20K	-2.32M
Net Income	-24.54M	-31.25M	-43.37M	-37.23M	-23.75M	-26.75M	-17.65M	-22.80M	-14.06M	-9.85M	66.20K	-2.32M
Selling & General & Admin	16.85M	16.39M	16.59M	16.71M	18.44M	18.44M	17.58M	8.89M	8.37M	6.96M	2.46M	2.99M
Research & Development	41.80M	52.98M	66.66M	46.53M	55.00M	41.49M	22.29M	19.70M	8.24M	5.60M	9.41M	10.85M
Other Expenses	13.91M	-8.17M	-3.69M	-3.66M	-26.00K	1.80M	-2.10M	119.50K	10.90K	3.00K	6.31K	-
Operating Expenses	72.57M	61.20M	79.56M	63.24M	73.44M	59.93M	39.87M	28.59M	16.61M	12.56M	9.33M	13.53M
Interest Expense	-	-	-	-	-	-	1.95M	2.32K	184.65K	2.65M	493.94K	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	280.86K
Cost & Expenses	72.57M	61.20M	79.56M	63.24M	73.44M	59.93M	39.87M	28.59M	16.61M	12.56M	9.33M	13.53M
Income Tax	-	-2.02M	-2.37M	164.00K	-1.71M	-312.00K	1.10M	161.97K	203.87K	-18	487.63K	22.00
Shares Outstanding (Basic)	1.13M	927.15K	806.84K	681.01K	632.81K	663.51K	549.14K	521.41K	429.91K	477.68K	477.68K	59.99K
Shares Outstanding (Diluted)	1.13M	927.15K	806.84K	681.01K	632.81K	663.51K	549.14K	521.41K	429.91K	477.68K	477.68K	59.99K
EPS (Basic)	-21.8	-33.71	-53.75	-54.67	-37.54	-40.32	-32.14	-43.73	-32.7	-20.62	0.45	-38.68
EPS (Diluted)	-21.8	-33.71	-53.75	-54.67	-37.54	-40.32	-32.14	-43.73	-32.7	-20.62	0.45	-38.68
EBITDA	-22.76M	-30.50M	-43.37M	-31.61M	-26.12M	-30.26M	-14.22M	-22.40M	-13.37M	-6.83M	938.50K	-1.80M
Depreciation & Amortization	1.78M	2.78M	2.37M	2.13M	1.04M	570.00K	369.00K	361.38K	307.91K	366.98K	384.68K	378.32K